Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism EIF4E inhibitors(Eukaryotic translation initiation factor 4E inhibitors), MNK1 inhibitors(MAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitors), MNK2 inhibitors(MAP kinase-interacting serine/threonine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult Acute Myeloblastic Leukemia | Preclinical | CN | 17 Apr 2023 |